Table 1.
Sociodemographic and clinical characteristics of COVID‐19 patients with psychiatric symptoms
| Patient | #1 | #2 | #3 | #4 | #5 |
|---|---|---|---|---|---|
| Sociodemographic characteristics | |||||
| Age | 58 | 48 | 25 | 34 | 26 |
| Gender | Male | Male | Male | Male | Male |
| Marital status | Married | Married | Single | Married | Single |
| Occupation | Pilot | Merchant | Military | Military | Military |
| Severity of COVID‐19 | Mild | Severe | Mild | Mild | Mild |
| Treatment for COVID‐19 | |||||
| Chloroquine | Yes | No | Yes | Yes | Yes |
| Dexamethasone | No | Yes | No | Yes | N |
| Day with psychiatric symptoms (relative to COVID‐19 diagnosis) | 56 | 30 | 17 | 11 | 12 |
| Neuropsychiatric exam findings | |||||
| Neurological exam | Normal | Normal | Normal | Altered | Normal |
| Delusions | Yes | Yes | Yes | Yes | Yes |
| Hallucinations | No | No | Yes | Yes | Yes |
| Disorganized speech | Yes | Yes | No | No | Yes |
| Altered affect | Yes | Yes | Yes | No | Yes |
| Vital signs | |||||
| Oxygen saturation (%) | 98 | 96 | 96 | 97 | 98 |
| Temperature (°C) | 36.5 | 36.9 | 37 | 36.5 | 36.5 |
| Blood pressure (mmHg) | 130/90 | 135/80 | 120/80 | 125/80 | 130/80 |
| Heart rate (bpm) | 98 | 102 | 96 | 95 | 109 |
| Laboratory diagnostics | |||||
| Leukocytes (4.3–12.3 × 103/μl) | 7.2 | 8.2 | 12.1 | 18.1 | 10.2 |
| Hemoglobin (13.6–17.2 g/dl) | 14.1 | 15 | 13.2 | 14.8 | 13.1 |
| Platelets (150–388 × 103/μl) | 182 | 148 | 380 | 468 | 263 |
| Neutrophils (%) | 70 | 90 | 75 | 70 | 80 |
| Lymphocytes (%) | 24 | 7 | 20 | 20 | 17 |
| Erythrocyte sedimentation rate (0–22 mm/h) | 10 | 15 | 15 | 15 | 20 |
| Glucose (70–110 mg/dl) | 87 | 92 | 75 | 84 | 70 |
| Creatinine (0.4–1.4 mg/dl) | 0,9 | 0.8 | 1.05 | 1.02 | 1.3 |
| AST (8–48 U/L) | 23 | 18 | NA | 37 | 19 |
| ALT (7–55 U/L) | 30 | 26 | NA | 107 | 13 |
| Sodium (136–145 mg/dl) | 142 | 138 | 135 | 133 | NA |
| Potassium (3.5–5.2 mg/dl) | 3.8 | 3.7 | 3.9 | 4.2 | NA |
| Chlorine (98–108 mg/dl) | 100 | 102 | 99 | 95 | NA |
| Lactate dehydrogenase (0–248 U/L) | 252 | 260 | NA | 270 | NA |
| C‐reactive protein (0–1 mg/dl) | 0.6 | 1.4 | NA | 0.03 | 1.2 |
| Neurological studies | |||||
| Brain magnetic resonance | Normal | NA | NA | Normal | NA |
| Head computed tomography | NA | Normal | Normal | NA | Normal |
| Electroencephalogram | NA | NA | NA | Normal | NA |
| Cerebrospinal fluid analysis | Normal | NA | NA | NA | NA |
| Neuropsychiatric diagnosis | Bipolar I disorder | Manic episode | Major depressive episode with psychotic features | Brief psychotic disorder | Brief psychotic disorder |
Abbreviations: COVID‐19, coronavirus disease 2019; mmHg, millimetres of mercury; bpm, beats per minute; mm/h: millimeters per hour; mg/dl: miligrams per deciliter; ALT, alanine aminotransferase; AST, aspartate aminotransferase; NA, not available.